在临床应用中揭示介质干细胞的再生潜力:对miRNA和lncRNA影响的洞察
Maurycy Jankowski1,2, Maryam Farzaneh3, Farhoodeh Ghaedrahmati4
1Department of Computer Science and Statistics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.
Cells
|November 10, 2023
概括
介酶干细胞 (MSC) 分化成各种细胞类型,由微RNA (miRNA) 和长非编码RNA (lncRNA) 调节. 利用这些分子为疾病和再生医学提供了有前途的精确疗法.
科学领域:
- 干细胞生物学 干细胞生物学
- 分子调节差异化的分化.
- 再生医学是一种再生医学.
背景情况:
- 介质细胞干细胞 (MSCs) 表现出多能性,分化为多种细胞系.
- 长非编码RNAs (lncRNAs) 是认可的MSC分化的调节者.
- 在MSC功能中的microRNAs (miRNAs) 和lncRNAs之间的相互作用需要阐明.
研究的目的:
- 探索miRNAs和lncRNAs在MSC分化和功能中的调节作用.
- 审查MSCs的当前文献和临床研究,重点关注miRNA和lncRNA应用.
- 突出miRNAs和lncRNAs在基于MSC的再生策略中的治疗潜力.
主要方法:
- 公共数据库的文献综述,用于研究人类干细胞.
- 关于MSC应用的临床研究汇编.
- 对miRNA和lncRNA参与MSCs的研究进行分析.
主要成果:
- 多国企业拥有显著的差异化能力.
- miRNAs和lncRNAs在调节MSC功能和分化途径方面发挥着至关重要的作用.
- 现有的文献和临床数据支持在MSC中准miRNA和lncRNA的治疗潜力.
结论:
- miRNAs和lncRNAs是MSCs的关键调节者,为创新的疾病治疗提供了途径.
- 在MSC中利用miRNAs和lncRNAs为精确和个性化的再生疗法提供了机会.
- 对miRNAs和lncRNAs进行进一步的研究是必不可少的,以释放MSCs的全部再生潜力.
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K


